Publication Name	World Journal of Diabetes
Manuscript ID	94745
Country	Kuwait

Received	2024-03-24 13:51
Peer-Review Started	2024-03-24 13:51
To Make the First Decision
Return for Revision	2024-05-08 03:06
Revised	2024-05-20 05:32
Second Decision	2024-06-17 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-17 07:19
Articles in Press	2024-06-17 07:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-28 13:31
Publish the Manuscript Online	2024-08-27 15:11

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Biochemical Research Methods
Manuscript Type	Editorial
Article Title	MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease
Manuscript Source	Invited Manuscript
All Author List	Ashraf Al Madhoun
Funding Agency and Grant Number	Funding Agency Grant Number Kuwait Foundation for the Advancement of Sciences and Dasman Diabetes Institute, Kuwait RACB-2021-007
Corresponding Author	Ashraf Al Madhoun, PhD, Academic Research, Senior Scientist, Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Jassim AlBahar Street, Dasman 15400, Kuwait. ashraf.madhoun@dasmainstitute.org
Key Words	Diabetic kidney disease; MicroRNA; MicroRNA-630; Toll-like receptor 4; Inflammation
Core Tip	Wu et al identified microRNA-630 as a promising candidate for the management of diabetic kidney disease, exerting its protective effects through the regulation of toll-like receptor 4-mediated inflammatory pathways. Further research elucidating the precise molecular mechanisms underlying microRNA-630’s actions and its therapeutic potential is warranted, with the ultimate goal of developing targeted interventions to alleviate the burden of diabetic kidney disease and improve patient outcomes.
Publish Date	2024-08-27 15:11
Citation	<p>Al Madhoun A. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. <i>World J Diabetes</i> 2024; 15(9): 1837-1841</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i9/1837.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i9.1837

Full Article (PDF)	WJD-15-1837-with-cover.pdf
Full Article (Word)	WJD-15-1837.docx
Manuscript File	94745_Auto_Edited-YJP.docx
Answering Reviewers	94745-answering-reviewers.pdf
Audio Core Tip	94745-audio.mp3
Conflict-of-Interest Disclosure Form	94745-conflict-of-interest-statement.pdf
Copyright License Agreement	94745-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	94745-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	94745-non-native-speakers.pdf
Peer-review Report	94745-peer-reviews.pdf
Scientific Misconduct Check	94745-scientific-misconduct-check.png
Scientific Editor Work List	94745-scientific-editor-work-list.pdf
CrossCheck Report	94745-crosscheck-report.pdf